Anand Patel(@Anand_88_Patel) 's Twitter Profileg
Anand Patel

@Anand_88_Patel

Leukemia & myeloid malignancy doctor. tweets=mine. RT≠endorsement. He/him

ID:2417458314

linkhttps://scholar.google.com/citations?user=kNhjy-MAAAAJ&hl=en calendar_today29-03-2014 13:54:02

6,3K Tweets

4,8K Followers

1,2K Following

Carmelo Gurnari(@CarmeloGurnari) 's Twitter Profile Photo

It’s MDS and HSCT week!!!🤩 off the press in Blood Journal 👉Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms? ashpublications.org/blood/article-…

It’s MDS and HSCT week!!!🤩 off the press in @BloodJournal 👉Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms? ashpublications.org/blood/article-…
account_circle
Amer Zeidan MBBS,MHS ‏عامر زيدان(@Dr_AmerZeidan) 's Twitter Profile Photo

Excellent international collaboration led by GenoMed4All # Dr. Della Porta on using IPSS-M Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

account_circle
Anand Patel(@Anand_88_Patel) 's Twitter Profile Photo

A very nice paper in Blood Advances by Dr Wieduwilt on clinical trial endpoints in ALL studies and highlighting the heterogeneity across various Phase II/III studies

ashpublications.org/bloodadvances/…

A very nice paper in @BloodAdvances by Dr Wieduwilt on clinical trial endpoints in ALL studies and highlighting the heterogeneity across various Phase II/III studies ashpublications.org/bloodadvances/…
account_circle
Charlie Foucar(@CharlieFoucar) 's Twitter Profile Photo

Excellent review of the current landscape of IDH1/2 mutated AML. Highly recommend. nature.com/articles/s4137…

account_circle
Andrew Kuykendall MD(@KuykendallMd) 's Twitter Profile Photo

Check out this amazing work from Seongseok Yun + Nicole Vincellete. Helps explain what may drive 'triple-negative' MF and provides rationale for our IIT using the JAK2/BRD4 inhibitor fedratinib (which can downregulate myc) in proliferative MDS/MPN. aacrjournals.org/bloodcancerdis…

account_circle
Eman Abdelhadi(@emanabdelhadi) 's Twitter Profile Photo

The point of this raid was terror. They waited for those kids to fall asleep. And then they pulled the tents from under them while they were sleeping. Shame on the University of Chicago.

account_circle
Anand Patel(@Anand_88_Patel) 's Twitter Profile Photo

More from Jad Othman et al re NPM1m AML getting intensive therapy!
-FLT3-ITD, DNMT3A, WT1, non-ABD NPM1 assoc w/ MRD+ & worse OS (all but FLT3-ITD assoc w/ relapse in MRD- dz)
-difficult to identify groups benefiting from allo when NPM1 MRD- post 2 cycles

sciencedirect.com/science/articl…

More from @jadothm et al re NPM1m AML getting intensive therapy! -FLT3-ITD, DNMT3A, WT1, non-ABD NPM1 assoc w/ MRD+ & worse OS (all but FLT3-ITD assoc w/ relapse in MRD- dz) -difficult to identify groups benefiting from allo when NPM1 MRD- post 2 cycles sciencedirect.com/science/articl…
account_circle